Together We Rise

A Global Milestone in Precision Wellness
Launched in 2017 after three years of intensive development in Boston, MaVie represents a definitive milestone in the group’s history of scientific innovation. Developed by a world-class team of scientists from MIT and Harvard, the platform achieved rapid commercial validation and international acclaim. The brand’s success was cemented in 2021 with a landmark $20 million exit, following its acquisition by Arix, a publicly listed company in the United States.

At the heart of MaVie is a proprietary intelligence engine designed to translate complex genetic insights into actionable wellness protocols. By utilising state-of-the-art automation, the platform interprets DNA data alongside dynamic biological markers to produce tailored nutritional and lifestyle solutions. This sophisticated approach moved wellness beyond generic advice, creating a truly responsive biological partnership for the consumer.